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ties. However, here we focus on its role in reducingThe Hyperleptinemia of Obesity—
malonyl CoA formation.Regulator of Caloric Surpluses McGarry and Foster reported in 1978 that malonyl
CoA, the substrate generated by ACC for FA synthesis,
inhibits carnitine palmitoyl transferase I (CPT-1), the
rate-limiting enzyme of mitochondrial FA oxidation
New evidence suggests that leptin and other anorexi- (McGarry et al., 1978). In other words, the McGarry effect
genic agents reduce appetite by inactivating hypothal- on CPT-1 allows newly synthesized FA to be stored as
amic AMP-activated protein kinase (AMPK), thereby triacylglycerol (TG), rather than to be oxidized in a futile
increasing malonyl CoA levels. This preview examines cycle. This pivotal intersection between anabolism and
AMP biology and its role in malonyl-CoA generation catabolism is regulated by AMPK.
and attempts to integrate its central actions with its The Antisteatotic Action of Leptin
peripheral antilipotoxic actions within the context of In contrast to its hypothalamic action, leptin activates
leptin physiology in obesity. (phosphorylates) AMPK in skeletal muscle (Minokoshi
Appetite, AMP-Kinase, and Malonyl CoA
Within the past few months, three groups have reported
independently that AMP-activated protein kinase (AMPK),
the ubiquitous central “fuel gauge” of cells (Hardie and
Carling, 1997), may also regulate feeding behavior (An-
dersson et al., 2004; Minokoshi et al., 2004; Kim et al.,
2004), i.e., the enzyme that determines the metabolic
fate of ingested fuels also regulates their ingestion.
According to the first two groups, the anorexigenic adi-
pocyte hormone, leptin, inactivates (dephosphorylates)
AMPK in the hypothalamus, while Kim et al. report that
C75, a synthetic anorexigenic compound, does the
same (Figure 1). Since leptin activates AMPK in skeletal
muscle (Minokoshi et al., 2002) and probably other ex-
traneural tissues, AMPK inactivation in the hypothala-
mus is puzzling, perhaps reflecting complex “rewiring”
of leptin-responsive neurons (Pinto et al., 2004). Other
anorexigenic maneuvers such as intracerebroventricu-
lar administration of insulin, glucose, or MTII, a MC3
and 4 agonist, and refeeding (Andersson et al., 2004)
also inactivate AMPK and reduce food intake. Con-
versely, orexigenic factors, such as agouti-related pro-
tein (AGRP) (3), 5-aminoimidazole-4-carboxamide ribo-
side (AICAR), and ghrelin (Andersson et al., 2004),
phosphorylate (activate) hypothalamic AMPK, which phos-
phorylates (inactivates) ACC, thereby reducing malonyl
CoA production and increasing food intake.
Inactivation of AMPK reduces the phosphorylation of
acetyl CoA carboxylase (ACC), which increases its activ-
ity and thus enhances the production of malonyl CoA Figure 1. Obesity-Level Hyperleptinemia, AMPK and Malonyl CoA
(Figure 1). Malonyl CoA was previously proposed by The primary event in obesity is increased food intake, irrespective
Loftus et al. (2000) to reduce appetite. of cause. The resulting increase in insulin secretion induces hepatic
sterol regulatory element binding protein (SREBP)-1c, a transcrip-Some AMPK Biology
tion factor that upregulates the lipogenic enzymes. As adipocytesAMPK is a heterotrimer made up of catalytic  subunits
fatten, secretion of leptin rises. Leptin crosses the blood-brain bar-and regulatory  and  subunits. It is activated by phos-
rier (BBB) and dephosphorylates and thus inactivates (red box) hy-phorylation of threonine 172 in the activation loop of its
pothalamic AMPK, increasing ACC activity (green box) and malonyl
 subunit (Hardie and Carling, 1997). Activation is CoA formation. This limits food intake, restores caloric equilibrium,
caused by an increase in the AMP:ATP ratio following and establishes a new, albeit overweight, steady state.
In extraneural nonadipose tissues, hyperleptinemia phosphorylatesa decline in cellular ATP or by upstream kinases such
and thus activates (green box) AMPK, phosphorylating and thusas the AMPK-kinase complex (Hawley et al., 2003).
inactivating (red box) ACC. This reduces malonyl CoA formationPhosphorylated AMP kinase activates catabolic ATP-
(black and white arrow) and its inhibition of mitochondrial FA oxida-generating pathways, such as fatty acid oxidation, while
tion via CPT-1 (red X). FA oxidation is thus enhanced and lipogenesis
turning off anabolic ATP-consuming pathways such as reduced, effectively preventing steatosis and lipotoxicity (metabolic
fatty acid (FA) synthesis. AMP kinase has many addi- syndrome). (green box)  enzyme activation; (red box)  enzyme
inactivation. (black and white arrow)  very low level malonyl CoA.tional effects on gene and protein expression and activi-
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helpful suggestions and Jim Hardy and Kay McCorkle at the Depart-et al., 2002) and probably in other extraneural tissues.
ment of Veterans Affairs for figure illustration.Phosphorylated AMPK phosphorylates (inactivates)
ACC and lowers intracellular malonyl CoA. This reduces
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role of DIO hyperleptinemia. Weight gain begins when
the caloric balance becomes positive, but ultimately
weight reaches a plateau, indicating that caloric balance
has been restored. This reequilibration of caloric intake How Homologous Recombination
and expenditure in DIO may reflect the action of endoge- Is Initiated: Unexpected Evidencenous hyperleptinemia on the hypothalamus. Indeed, in
for Single-Strand Nicks fromleptin-deficient ob/ob mice, body weight reaches a pla-
teau only after they become helplessly immobilized by V(D)J Site-Specific Recombination
extreme obesity and unable to reach their food. It may
well be that the increase in hypothalamic malonyl CoA
generated by the action of leptin on AMPK prevents
Views of how homologous recombination is initiatedrodents and humans with DIO from reaching that pathet-
have changed over the past several decades: in theically helpless state.
In summary, the function of obesity-level hyperlepti- 1960s and 1970s, single-strand DNA lesions (nicks)
nemia is not to prevent or inhibit DIO, but rather to permit were the leading contenders, but in the last decade,
the stockpiling of calories within certain upper limits. double-strand DNA breaks (DSBs) have reigned. In this
Its peripheral AMPK-mediated actions partition the TG issue of Cell, Lee et al. present evidence that nicks
stores into the adipocyte compartment, thereby pro- can stimulate homologous recombination and, in un-
tecting nonadipose tissues from lipotoxicity. Its AMPK- controlled situations, may lead to translocations and
mediated hypothalamic actions on food intake ulti- other potentially dangerous genome rearrangements.
mately restore caloric balance, thereby preventing the
extreme, incapacitating obesity observed in complete Years before DSBs were generally accepted as initiators
leptin deficiency. of homologous recombination, Szostak et al. (1983) pro-
posed a model starting with a DSB (Figure 1, top). This
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